ONTOLOGY REPORT - ANNOTATIONS
| Term: | capsaicin |
|
| Accession: | CHEBI:3374
|
browse the term
|
| Definition: | A capsaicinoid that has formula C18H27NO3. |
| Synonyms: | exact_synonym: | (6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide |
| | related_synonym: | (E)-8-Methyl-N-vanillyl-6-nonenamide; C18H27NO3; COc1cc(CNC(=O)CCCC\\C=C\\C(C)C)ccc1O; InChI=1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6+; InChIKey=YKPUWZUDDOIDPM-SOFGYWHQSA-N; Isodecenoic acid vanillylamide; Zostrix; trans-8-Methyl-N-vanillyl-6-nonenamide |
| | xref_casrn: | 404-86-4 |
| | xref: | Beilstein:2816484 "Beilstein Registry Number"; ChEMBL:191783 "ChEMBL COMPOUND"; ChemIDplus:404-86-4 "CAS Registry Number"; KEGG COMPOUND:404-86-4 "CAS Registry Number"; KEGG COMPOUND:C06866 "KEGG COMPOUND"; KEGG DRUG:D00250 "KEGG DRUG" |
| | xref_mesh: | MESH:D002211 |
| | xref: | Wikipedia:Capsaicin "Wikipedia" |
|
|
capsaicin
|
| G |
ABCA1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
|
multiple interactions |
ISO |
9 |
107,543,283 |
107,690,527 |
RGD:6480464 |
CTD |
| G |
ABCA1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
|
increases response to substance |
ISO |
9 |
107,543,283 |
107,690,527 |
RGD:6480464 |
CTD |
| G |
ABCA1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
|
increases expression |
ISO |
9 |
107,543,283 |
107,690,527 |
RGD:6480464 |
CTD |
| G |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
multiple interactions |
EXP |
7 |
87,133,179 |
87,342,639 |
RGD:6480464 |
CTD |
| G |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
increases expression |
EXP |
7 |
87,133,179 |
87,342,639 |
RGD:6480464 |
CTD |
| G |
ABL1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
increases expression |
EXP |
9 |
133,589,268 |
133,763,062 |
RGD:6480464 |
CTD |
| G |
ACACB |
acetyl-CoA carboxylase beta |
|
decreases expression |
ISO |
12 |
109,577,202 |
109,706,031 |
RGD:6480464 |
CTD |
| G |
ACOX1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
EXP |
17 |
73,937,588 |
73,975,515 |
RGD:6480464 |
CTD |
| G |
ACSL3 |
acyl-CoA synthetase long-chain family member 3 |
|
decreases expression |
EXP |
2 |
223,725,732 |
223,808,119 |
RGD:6480464 |
CTD |
| G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
3 |
186,560,463 |
186,576,252 |
RGD:6480464 |
CTD |
| G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
3 |
186,560,463 |
186,576,252 |
RGD:6480464 |
CTD |
| G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
3 |
186,560,463 |
186,576,252 |
RGD:6480464 |
CTD |
| G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
3 |
186,560,463 |
186,576,252 |
RGD:6480464 |
CTD |
| G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
increases secretion |
ISO |
3 |
186,560,463 |
186,576,252 |
RGD:6480464 |
CTD |
| G |
ADRA2A |
adrenoceptor alpha 2A |
|
decreases response to substance |
ISO |
10 |
112,836,790 |
112,840,665 |
RGD:6480464 |
CTD |
| G |
AGA |
aspartylglucosaminidase |
|
decreases expression |
ISO |
4 |
178,351,928 |
178,363,657 |
RGD:6480464 |
CTD |
| G |
AGXT2L2 |
alanine-glyoxylate aminotransferase 2-like 2 |
|
increases expression |
ISO |
5 |
177,635,540 |
177,659,803 |
RGD:6480464 |
CTD |
| G |
AHR |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
7 |
17,338,276 |
17,385,775 |
RGD:6480464 |
CTD |
| G |
AKIRIN2 |
akirin 2 |
|
increases expression |
ISO |
6 |
88,384,578 |
88,411,985 |
RGD:6480464 |
CTD |
| G |
AKR1A1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
multiple interactions |
ISO |
1 |
46,016,455 |
46,035,723 |
RGD:6480464 |
CTD |
| G |
AKR7A3 |
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
|
multiple interactions |
ISO |
1 |
19,609,057 |
19,615,280 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases activity |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases expression |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
ALB |
albumin |
|
increases expression |
EXP |
4 |
74,269,972 |
74,287,129 |
RGD:6480464 |
CTD |
| G |
ALB |
albumin |
|
increases expression |
EXP |
4 |
74,269,972 |
74,287,129 |
RGD:6480464 |
CTD |
| G |
ALDH3A1 |
aldehyde dehydrogenase 3 family, member A1 |
|
decreases expression |
ISO |
17 |
19,641,297 |
19,651,746 |
RGD:6480464 |
CTD |
| G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
10 |
45,869,624 |
45,941,567 |
RGD:6480464 |
CTD |
| G |
ALOX5 |
arachidonate 5-lipoxygenase |
|
decreases activity |
ISO |
10 |
45,869,624 |
45,941,567 |
RGD:6480464 |
CTD |
| G |
AMHR2 |
anti-Mullerian hormone receptor, type II |
|
decreases expression |
ISO |
12 |
53,817,639 |
53,825,318 |
RGD:6480464 |
CTD |
| G |
AMN |
amnion associated transmembrane protein |
|
multiple interactions |
ISO |
14 |
103,388,993 |
103,397,179 |
RGD:6480464 |
CTD |
| G |
AMN |
amnion associated transmembrane protein |
|
increases expression |
ISO |
14 |
103,388,993 |
103,397,179 |
RGD:6480464 |
CTD |
| G |
ANGPT1 |
angiopoietin 1 |
|
increases expression |
EXP |
8 |
108,261,710 |
108,510,254 |
RGD:6480464 |
CTD |
| G |
ANGPT2 |
angiopoietin 2 |
|
increases expression |
EXP |
8 |
6,357,172 |
6,420,784 |
RGD:6480464 |
CTD |
| G |
APAF1 |
apoptotic peptidase activating factor 1 |
|
increases expression |
EXP |
12 |
99,039,078 |
99,129,211 |
RGD:6480464 |
CTD |
| G |
APOB |
apolipoprotein B (including Ag(x) antigen) |
|
increases expression |
ISO |
2 |
21,224,301 |
21,266,945 |
RGD:6480464 |
CTD |
| G |
APOC1 |
apolipoprotein C-I |
|
decreases expression |
EXP |
19 |
45,417,921 |
45,422,606 |
RGD:6480464 |
CTD |
| G |
APOE |
apolipoprotein E |
|
multiple interactions |
ISO |
19 |
45,409,039 |
45,412,650 |
RGD:6480464 |
CTD |
| G |
AQP1 |
aquaporin 1 (Colton blood group) |
|
increases response to substance |
ISO |
7 |
30,951,415 |
30,965,131 |
RGD:6480464 |
CTD |
| G |
AR |
androgen receptor |
|
multiple interactions |
EXP |
X |
66,763,874 |
66,950,461 |
RGD:6480464 |
CTD |
| G |
AR |
androgen receptor |
|
multiple interactions |
EXP |
X |
66,763,874 |
66,950,461 |
RGD:6480464 |
CTD |
| G |
AR |
androgen receptor |
|
increases expression |
EXP |
X |
66,763,874 |
66,950,461 |
RGD:6480464 |
CTD |
| G |
AREG |
amphiregulin |
|
multiple interactions |
ISO |
4 |
75,310,853 |
75,320,726 |
RGD:6480464 |
CTD |
| G |
ARPP19 |
cAMP-regulated phosphoprotein, 19kDa |
|
increases expression |
ISO |
15 |
52,839,432 |
52,861,213 |
RGD:6480464 |
CTD |
| G |
ATF3 |
activating transcription factor 3 |
|
multiple interactions |
EXP |
1 |
212,738,676 |
212,794,119 |
RGD:6480464 |
CTD |
| G |
ATF4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
increases expression |
EXP |
22 |
39,916,569 |
39,918,691 |
RGD:6480464 |
CTD |
| G |
ATF4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
increases expression |
EXP |
22 |
39,916,569 |
39,918,691 |
RGD:6480464 |
CTD |
| G |
ATF4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
multiple interactions |
EXP |
22 |
39,916,569 |
39,918,691 |
RGD:6480464 |
CTD |
| G |
ATG16L1 |
autophagy related 16-like 1 (S. cerevisiae) |
|
decreases expression |
ISO |
2 |
234,160,217 |
234,204,320 |
RGD:6480464 |
CTD |
| G |
ATG5 |
autophagy related 5 |
|
multiple interactions |
EXP |
6 |
106,632,352 |
106,773,695 |
RGD:6480464 |
CTD |
| G |
ATG5 |
autophagy related 5 |
|
increases expression |
EXP |
6 |
106,632,352 |
106,773,695 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
multiple interactions |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
increases activity |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
increases expression |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
increases phosphorylation |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
affects metabolic processing |
ISO |
12 |
110,719,032 |
110,788,898 |
RGD:6480464 |
CTD |
| G |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression |
ISO |
12 |
110,719,032 |
110,788,898 |
RGD:6480464 |
CTD |
| G |
ATP6AP1 |
ATPase, H+ transporting, lysosomal accessory protein 1 |
|
decreases expression |
ISO |
X |
153,656,978 |
153,664,862 |
RGD:6480464 |
CTD |
| G |
BAD |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
11 |
64,037,300 |
64,052,176 |
RGD:6480464 |
CTD |
| G |
BAG3 |
BCL2-associated athanogene 3 |
|
increases expression |
EXP |
10 |
121,410,882 |
121,437,331 |
RGD:6480464 |
CTD |
| G |
BAK1 |
BCL2-antagonist/killer 1 |
|
increases activity |
ISO |
6 |
33,540,323 |
33,548,070 |
RGD:6480464 |
CTD |
| G |
BAK1 |
BCL2-antagonist/killer 1 |
|
increases expression |
EXP |
6 |
33,540,323 |
33,548,070 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
affects localization |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases activity |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BCAN |
brevican |
|
decreases expression |
ISO |
1 |
156,611,740 |
156,629,324 |
RGD:6480464 |
CTD |
| G |
BCL10 |
B-cell CLL/lymphoma 10 |
|
increases expression |
EXP |
1 |
85,731,459 |
85,742,587 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases response to substance |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2L1 |
BCL2-like 1 |
|
increases expression |
EXP |
20 |
30,252,261 |
30,310,656 |
RGD:6480464 |
CTD |
| G |
BCL2L1 |
BCL2-like 1 |
|
decreases expression |
EXP |
20 |
30,252,261 |
30,310,656 |
RGD:6480464 |
CTD |
| G |
BCLAF1 |
BCL2-associated transcription factor 1 |
|
increases expression |
EXP |
6 |
136,578,001 |
136,610,989 |
RGD:6480464 |
CTD |
| G |
BDKRB1 |
bradykinin receptor B1 |
|
multiple interactions |
ISO |
14 |
96,722,547 |
96,731,100 |
RGD:6480464 |
CTD |
| G |
BDKRB1 |
bradykinin receptor B1 |
|
increases expression |
ISO |
14 |
96,722,547 |
96,731,100 |
RGD:6480464 |
CTD |
| G |
BDKRB2 |
bradykinin receptor B2 |
|
multiple interactions |
ISO |
14 |
96,671,135 |
96,710,666 |
RGD:6480464 |
CTD |
| G |
BDNF |
brain-derived neurotrophic factor |
|
multiple interactions |
ISO |
11 |
27,676,440 |
27,743,605 |
RGD:6480464 |
CTD |
| G |
BDNF |
brain-derived neurotrophic factor |
|
affects expression |
ISO |
11 |
27,676,440 |
27,743,605 |
RGD:6480464 |
CTD |
| G |
BECN1 |
beclin 1, autophagy related |
|
increases expression |
ISO |
17 |
40,962,150 |
40,976,310 |
RGD:6480464 |
CTD |
| G |
BID |
BH3 interacting domain death agonist |
|
multiple interactions |
EXP |
22 |
18,216,906 |
18,257,431 |
RGD:6480464 |
CTD |
| G |
BID |
BH3 interacting domain death agonist |
|
increases cleavage |
EXP |
22 |
18,216,906 |
18,257,431 |
RGD:6480464 |
CTD |
| G |
BID |
BH3 interacting domain death agonist |
|
increases expression |
EXP |
22 |
18,216,906 |
18,257,431 |
RGD:6480464 |
CTD |
| G |
BIRC2 |
baculoviral IAP repeat containing 2 |
|
increases expression |
EXP |
11 |
102,217,913 |
102,249,401 |
RGD:6480464 |
CTD |
| G |
BIRC5 |
baculoviral IAP repeat containing 5 |
|
multiple interactions |
EXP |
17 |
76,210,277 |
76,221,716 |
RGD:6480464 |
CTD |
| G |
BIRC5 |
baculoviral IAP repeat containing 5 |
|
decreases expression |
EXP |
17 |
76,210,277 |
76,221,716 |
RGD:6480464 |
CTD |
| G |
BIRC5 |
baculoviral IAP repeat containing 5 |
|
decreases expression |
EXP |
17 |
76,210,277 |
76,221,716 |
RGD:6480464 |
CTD |
| G |
BIRC5 |
baculoviral IAP repeat containing 5 |
|
decreases expression |
EXP |
17 |
76,210,277 |
76,221,716 |
RGD:6480464 |
CTD |
| G |
BIRC8 |
baculoviral IAP repeat containing 8 |
|
decreases expression |
EXP |
19 |
53,792,854 |
53,794,875 |
RGD:6480464 |
CTD |
| G |
BNIP2 |
BCL2/adenovirus E1B 19kDa interacting protein 2 |
|
increases expression |
EXP |
15 |
59,955,061 |
59,981,642 |
RGD:6480464 |
CTD |
| G |
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
|
decreases expression |
EXP |
10 |
133,781,204 |
133,795,435 |
RGD:6480464 |
CTD |
| G |
BNIP3L |
BCL2/adenovirus E1B 19kDa interacting protein 3-like |
|
decreases expression |
EXP |
8 |
26,240,523 |
26,270,644 |
RGD:6480464 |
CTD |
| G |
CACNG3 |
calcium channel, voltage-dependent, gamma subunit 3 |
|
decreases expression |
ISO |
16 |
24,266,874 |
24,373,737 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
increases secretion |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
decreases expression |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
increases expression |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
increases secretion |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
decreases expression |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
increases expression |
EXP |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
increases expression |
EXP |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
increases secretion |
EXP |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
affects response to substance |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
increases secretion |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
increases expression |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
decreases expression |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
increases expression |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
increases secretion |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CALCB |
calcitonin-related polypeptide beta |
|
decreases activity |
EXP |
11 |
15,095,146 |
15,100,177 |
RGD:6480464 |
CTD |
| G |
CALCB |
calcitonin-related polypeptide beta |
|
increases expression |
EXP |
11 |
15,095,146 |
15,100,177 |
RGD:6480464 |
CTD |
| G |
CALCB |
calcitonin-related polypeptide beta |
|
increases secretion |
EXP |
11 |
15,095,146 |
15,100,177 |
RGD:6480464 |
CTD |
| G |
CALCB |
calcitonin-related polypeptide beta |
|
multiple interactions |
EXP |
11 |
15,095,146 |
15,100,177 |
RGD:6480464 |
CTD |
| G |
CALCB |
calcitonin-related polypeptide beta |
|
multiple interactions |
ISO |
11 |
15,095,146 |
15,100,177 |
RGD:6480464 |
CTD |
| G |
CAMK2A |
calcium/calmodulin-dependent protein kinase II alpha |
|
multiple interactions |
ISO |
5 |
149,599,054 |
149,669,403 |
RGD:6480464 |
CTD |
| G |
CASP2 |
caspase 2, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
7 |
142,985,308 |
143,004,789 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases cleavage |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases cleavage |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases cleavage |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
affects expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
11 |
104,813,594 |
104,839,325 |
RGD:6480464 |
CTD |
| G |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
11 |
104,813,594 |
104,839,325 |
RGD:6480464 |
CTD |
| G |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
11 |
104,813,594 |
104,839,325 |
RGD:6480464 |
CTD |
| G |
CASP6 |
caspase 6, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
110,609,785 |
110,624,629 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
decreases expression |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases cleavage |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
affects expression |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
EXP |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
EXP |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CCK |
cholecystokinin |
|
multiple interactions |
ISO |
3 |
42,299,318 |
42,307,662 |
RGD:6480464 |
CTD |
| G |
CCK |
cholecystokinin |
|
multiple interactions |
ISO |
3 |
42,299,318 |
42,307,662 |
RGD:6480464 |
CTD |
| G |
CCL19 |
chemokine (C-C motif) ligand 19 |
|
increases expression |
ISO |
9 |
34,689,567 |
34,691,274 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
decreases secretion |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
decreases secretion |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
ISO |
2 |
228,678,558 |
228,682,280 |
RGD:6480464 |
CTD |
| G |
CCL20 |
chemokine (C-C motif) ligand 20 |
|
multiple interactions |
ISO |
2 |
228,678,558 |
228,682,280 |
RGD:6480464 |
CTD |
| G |
CCL22 |
chemokine (C-C motif) ligand 22 |
|
multiple interactions |
ISO |
16 |
57,392,695 |
57,400,102 |
RGD:6480464 |
CTD |
| G |
CCL22 |
chemokine (C-C motif) ligand 22 |
|
increases expression |
ISO |
16 |
57,392,695 |
57,400,102 |
RGD:6480464 |
CTD |
| G |
CCL3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
EXP |
17 |
34,415,602 |
34,417,506 |
RGD:6480464 |
CTD |
| G |
CCL3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
ISO |
17 |
34,415,602 |
34,417,506 |
RGD:6480464 |
CTD |
| G |
CCL3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
17 |
34,415,602 |
34,417,506 |
RGD:6480464 |
CTD |
| G |
CCNA2 |
cyclin A2 |
|
decreases expression |
EXP |
4 |
122,737,599 |
122,745,088 |
RGD:6480464 |
CTD |
| G |
CCNB1 |
cyclin B1 |
|
decreases expression |
EXP |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
decreases expression |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
decreases expression |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCNL1 |
cyclin L1 |
|
increases expression |
ISO |
3 |
156,865,585 |
156,878,482 |
RGD:6480464 |
CTD |
| G |
CCR4 |
chemokine (C-C motif) receptor 4 |
|
increases expression |
ISO |
3 |
32,993,066 |
32,996,403 |
RGD:6480464 |
CTD |
| G |
CCR4 |
chemokine (C-C motif) receptor 4 |
|
multiple interactions |
ISO |
3 |
32,993,066 |
32,996,403 |
RGD:6480464 |
CTD |
| G |
CD46 |
CD46 molecule, complement regulatory protein |
|
increases expression |
ISO |
1 |
207,925,383 |
207,968,861 |
RGD:6480464 |
CTD |
| G |
CD68 |
CD68 molecule |
|
decreases expression |
ISO |
17 |
7,482,805 |
7,485,429 |
RGD:6480464 |
CTD |
| G |
CD80 |
CD80 molecule |
|
increases expression |
ISO |
3 |
119,243,140 |
119,278,481 |
RGD:6480464 |
CTD |
| G |
CD80 |
CD80 molecule |
|
multiple interactions |
ISO |
3 |
119,243,140 |
119,278,481 |
RGD:6480464 |
CTD |
| G |
CD8B |
CD8b molecule |
|
increases expression |
ISO |
2 |
87,042,460 |
87,089,047 |
RGD:6480464 |
CTD |
| G |
CDC14A |
cell division cycle 14A |
|
increases expression |
ISO |
1 |
100,818,023 |
100,985,833 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK2 |
cyclin-dependent kinase 2 |
|
decreases expression |
EXP |
12 |
56,360,556 |
56,366,568 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
decreases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
decreases expression |
EXP |
12 |
12,870,302 |
12,875,305 |
RGD:6480464 |
CTD |
| G |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
increases expression |
EXP |
12 |
12,870,302 |
12,875,305 |
RGD:6480464 |
CTD |
| G |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
increases expression |
ISO |
12 |
12,870,302 |
12,875,305 |
RGD:6480464 |
CTD |
| G |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
EXP |
9 |
21,967,751 |
21,994,490 |
RGD:6480464 |
CTD |
| G |
CEBPA |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
19 |
33,790,840 |
33,793,430 |
RGD:6480464 |
CTD |
| G |
CEBPA |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
19 |
33,790,840 |
33,793,430 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases activity |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
EXP |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CFL1 |
cofilin 1 (non-muscle) |
|
multiple interactions |
EXP |
11 |
65,622,282 |
65,625,804 |
RGD:6480464 |
CTD |
| G |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
|
decreases expression |
EXP |
2 |
201,980,877 |
202,037,411 |
RGD:6480464 |
CTD |
| G |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
|
increases expression |
EXP |
2 |
201,980,877 |
202,037,411 |
RGD:6480464 |
CTD |
| G |
CFTR |
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
|
increases activity |
ISO |
7 |
117,120,017 |
117,308,719 |
RGD:6480464 |
CTD |
| G |
CHEK2 |
checkpoint kinase 2 |
|
increases expression |
EXP |
22 |
29,083,731 |
29,137,822 |
RGD:6480464 |
CTD |
| G |
CIITA |
class II, major histocompatibility complex, transactivator |
|
multiple interactions |
ISO |
16 |
10,971,055 |
11,018,840 |
RGD:6480464 |
CTD |
| G |
CLDN1 |
claudin 1 |
|
increases expression |
ISO |
3 |
190,023,490 |
190,040,235 |
RGD:6480464 |
CTD |
| G |
CLEC2D |
C-type lectin domain family 2, member D |
|
decreases expression |
ISO |
12 |
9,822,304 |
9,852,151 |
RGD:6480464 |
CTD |
| G |
CLK1 |
CDC-like kinase 1 |
|
increases expression |
ISO |
2 |
201,717,732 |
201,729,467 |
RGD:6480464 |
CTD |
| G |
CNR1 |
cannabinoid receptor 1 (brain) |
|
increases activity |
ISO |
6 |
88,849,583 |
88,875,767 |
RGD:6480464 |
CTD |
| G |
CNR1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
ISO |
6 |
88,849,583 |
88,875,767 |
RGD:6480464 |
CTD |
| G |
CNR1 |
cannabinoid receptor 1 (brain) |
|
affects response to substance |
ISO |
6 |
88,849,583 |
88,875,767 |
RGD:6480464 |
CTD |
| G |
CNTF |
ciliary neurotrophic factor |
|
increases expression |
ISO |
11 |
58,390,146 |
58,393,206 |
RGD:6480464 |
CTD |
| G |
CNTF |
ciliary neurotrophic factor |
|
multiple interactions |
ISO |
11 |
58,390,146 |
58,393,206 |
RGD:6480464 |
CTD |
| G |
CNTFR |
ciliary neurotrophic factor receptor |
|
multiple interactions |
ISO |
9 |
34,551,430 |
34,590,138 |
RGD:6480464 |
CTD |
| G |
CNTFR |
ciliary neurotrophic factor receptor |
|
increases expression |
ISO |
9 |
34,551,430 |
34,590,138 |
RGD:6480464 |
CTD |
| G |
COL18A1 |
collagen, type XVIII, alpha 1 |
|
increases expression |
EXP |
21 |
46,825,097 |
46,933,634 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL3A1 |
collagen, type III, alpha 1 |
|
increases expression |
ISO |
2 |
189,839,099 |
189,877,472 |
RGD:6480464 |
CTD |
| G |
COX4I1 |
cytochrome c oxidase subunit IV isoform 1 |
|
increases expression |
ISO |
16 |
85,833,173 |
85,840,608 |
RGD:6480464 |
CTD |
| G |
COX5A |
cytochrome c oxidase subunit Va |
|
increases expression |
EXP |
15 |
75,212,616 |
75,230,495 |
RGD:6480464 |
CTD |
| G |
COX6A1 |
cytochrome c oxidase subunit VIa polypeptide 1 |
|
increases expression |
ISO |
12 |
120,875,893 |
120,878,545 |
RGD:6480464 |
CTD |
| G |
CPT1A |
carnitine palmitoyltransferase 1A (liver) |
|
multiple interactions |
EXP |
11 |
68,522,088 |
68,609,399 |
RGD:6480464 |
CTD |
| G |
CPT1A |
carnitine palmitoyltransferase 1A (liver) |
|
increases expression |
EXP |
11 |
68,522,088 |
68,609,399 |
RGD:6480464 |
CTD |
| G |
CPT1A |
carnitine palmitoyltransferase 1A (liver) |
|
multiple interactions |
ISO |
11 |
68,522,088 |
68,609,399 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
ISO |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSNK2A1 |
casein kinase 2, alpha 1 polypeptide |
|
increases phosphorylation |
EXP |
20 |
463,338 |
524,482 |
RGD:6480464 |
CTD |
| G |
CSNK2B |
casein kinase 2, beta polypeptide |
|
increases phosphorylation |
EXP |
6 |
31,633,657 |
31,637,843 |
RGD:6480464 |
CTD |
| G |
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
|
increases expression |
ISO |
3 |
41,240,942 |
41,281,939 |
RGD:6480464 |
CTD |
| G |
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
|
multiple interactions |
ISO |
3 |
41,240,942 |
41,281,939 |
RGD:6480464 |
CTD |
| G |
CX3CL1 |
chemokine (C-X3-C motif) ligand 1 |
|
affects expression |
ISO |
16 |
57,406,414 |
57,418,956 |
RGD:6480464 |
CTD |
| G |
CX3CL1 |
chemokine (C-X3-C motif) ligand 1 |
|
multiple interactions |
ISO |
16 |
57,406,414 |
57,418,956 |
RGD:6480464 |
CTD |
| G |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
ISO |
4 |
76,942,269 |
76,944,689 |
RGD:6480464 |
CTD |
| G |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
ISO |
4 |
76,942,269 |
76,944,689 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
ISO |
4 |
74,861,359 |
74,864,416 |
RGD:6480464 |
CTD |
| G |
CXCL5 |
chemokine (C-X-C motif) ligand 5 |
|
multiple interactions |
ISO |
4 |
74,861,359 |
74,864,416 |
RGD:6480464 |
CTD |
| G |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
2 |
136,871,919 |
136,875,725 |
RGD:6480464 |
CTD |
| G |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
ISO |
2 |
136,871,919 |
136,875,725 |
RGD:6480464 |
CTD |
| G |
CYBB |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
ISO |
X |
37,639,270 |
37,672,714 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
affects expression |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
decreases activity |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP2C19 |
cytochrome P450, family 2, subfamily C, polypeptide 19 |
|
decreases activity |
EXP |
10 |
96,522,463 |
96,612,671 |
RGD:6480464 |
CTD |
| G |
CYP2C9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
decreases activity |
EXP |
10 |
96,698,415 |
96,749,148 |
RGD:6480464 |
CTD |
| G |
CYP2D6 |
cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
decreases activity |
EXP |
22 |
42,522,501 |
42,526,883 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases expression |
ISO |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
DBH |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
decreases expression |
ISO |
9 |
136,501,485 |
136,524,466 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
increases expression |
EXP |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
increases expression |
EXP |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
increases expression |
EXP |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
increases expression |
EXP |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
increases expression |
ISO |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DFFA |
DNA fragmentation factor, 45kDa, alpha polypeptide |
|
decreases expression |
EXP |
1 |
10,520,588 |
10,532,613 |
RGD:6480464 |
CTD |
| G |
DPP3 |
dipeptidyl-peptidase 3 |
|
decreases expression |
ISO |
11 |
66,247,484 |
66,277,130 |
RGD:6480464 |
CTD |
| G |
DUSP1 |
dual specificity phosphatase 1 |
|
multiple interactions |
EXP |
5 |
172,195,093 |
172,198,203 |
RGD:6480464 |
CTD |
| G |
E2F1 |
E2F transcription factor 1 |
|
increases expression |
EXP |
20 |
32,263,292 |
32,274,210 |
RGD:6480464 |
CTD |
| G |
EDN1 |
endothelin 1 |
|
decreases activity |
EXP |
6 |
12,290,529 |
12,297,427 |
RGD:6480464 |
CTD |
| G |
EDN1 |
endothelin 1 |
|
multiple interactions |
EXP |
6 |
12,290,529 |
12,297,427 |
RGD:6480464 |
CTD |
| G |
EDN1 |
endothelin 1 |
|
multiple interactions |
EXP |
6 |
12,290,529 |
12,297,427 |
RGD:6480464 |
CTD |
| G |
EEF2 |
eukaryotic translation elongation factor 2 |
|
multiple interactions |
ISO |
19 |
3,976,054 |
3,985,461 |
RGD:6480464 |
CTD |
| G |
EGF |
epidermal growth factor |
|
multiple interactions |
EXP |
4 |
110,834,040 |
110,934,118 |
RGD:6480464 |
CTD |
| G |
EGF |
epidermal growth factor |
|
decreases expression |
ISO |
4 |
110,834,040 |
110,934,118 |
RGD:6480464 |
CTD |
| G |
EGF |
epidermal growth factor |
|
decreases activity |
ISO |
4 |
110,834,040 |
110,934,118 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
decreases expression |
ISO |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
multiple interactions |
EXP |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
decreases expression |
EXP |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
multiple interactions |
EXP |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
increases phosphorylation |
EXP |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
multiple interactions |
EXP |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
increases expression |
ISO |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EIF2A |
eukaryotic translation initiation factor 2A, 65kDa |
|
increases phosphorylation |
EXP |
3 |
150,264,574 |
150,303,803 |
RGD:6480464 |
CTD |
| G |
EIF2A |
eukaryotic translation initiation factor 2A, 65kDa |
|
increases phosphorylation |
ISO |
3 |
150,264,574 |
150,303,803 |
RGD:6480464 |
CTD |
| G |
EIF2S1 |
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
|
increases phosphorylation |
EXP |
14 |
67,827,034 |
67,853,233 |
RGD:6480464 |
CTD |
| G |
ELN |
elastin |
|
increases expression |
ISO |
7 |
73,442,427 |
73,484,237 |
RGD:6480464 |
CTD |
| G |
ENO2 |
enolase 2 (gamma, neuronal) |
|
multiple interactions |
ISO |
12 |
7,023,614 |
7,032,859 |
RGD:6480464 |
CTD |
| G |
ENOX2 |
ecto-NOX disulfide-thiol exchanger 2 |
|
increases response to substance |
EXP |
X |
129,757,355 |
130,037,208 |
RGD:6480464 |
CTD |
| G |
EPOR |
erythropoietin receptor |
|
increases expression |
ISO |
19 |
11,487,881 |
11,495,018 |
RGD:6480464 |
CTD |
| G |
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
decreases expression |
EXP |
17 |
37,844,393 |
37,884,915 |
RGD:6480464 |
CTD |
| G |
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
affects expression |
EXP |
17 |
37,844,393 |
37,884,915 |
RGD:6480464 |
CTD |
| G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
|
increases expression |
EXP |
17 |
62,120,390 |
62,207,502 |
RGD:6480464 |
CTD |
| G |
ERRFI1 |
ERBB receptor feedback inhibitor 1 |
|
multiple interactions |
ISO |
1 |
8,071,779 |
8,086,393 |
RGD:6480464 |
CTD |
| G |
ERRFI1 |
ERBB receptor feedback inhibitor 1 |
|
increases expression |
ISO |
1 |
8,071,779 |
8,086,393 |
RGD:6480464 |
CTD |
| G |
ETFA |
electron-transfer-flavoprotein, alpha polypeptide |
|
multiple interactions |
ISO |
15 |
76,508,628 |
76,603,810 |
RGD:6480464 |
CTD |
| G |
EXOSC8 |
exosome component 8 |
|
decreases expression |
ISO |
13 |
37,574,678 |
37,583,751 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II (thrombin) |
|
affects expression |
ISO |
11 |
46,740,743 |
46,761,056 |
RGD:6480464 |
CTD |
| G |
F2RL1 |
coagulation factor II (thrombin) receptor-like 1 |
|
multiple interactions |
EXP |
5 |
76,114,833 |
76,131,140 |
RGD:6480464 |
CTD |
| G |
FABP4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
8 |
82,390,732 |
82,395,473 |
RGD:6480464 |
CTD |
| G |
FABP4 |
fatty acid binding protein 4, adipocyte |
|
decreases expression |
EXP |
8 |
82,390,732 |
82,395,473 |
RGD:6480464 |
CTD |
| G |
FABP5 |
fatty acid binding protein 5 (psoriasis-associated) |
|
decreases expression |
EXP |
8 |
82,192,718 |
82,197,012 |
RGD:6480464 |
CTD |
| G |
FADD |
Fas (TNFRSF6)-associated via death domain |
|
increases expression |
ISO |
11 |
70,049,269 |
70,053,508 |
RGD:6480464 |
CTD |
| G |
FADD |
Fas (TNFRSF6)-associated via death domain |
|
multiple interactions |
ISO |
11 |
70,049,269 |
70,053,508 |
RGD:6480464 |
CTD |
| G |
FAM162A |
family with sequence similarity 162, member A |
|
decreases expression |
ISO |
3 |
122,103,023 |
122,128,961 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
affects expression |
EXP |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
EXP |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
ISO |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
ISO |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
EXP |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FASLG |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
172,628,185 |
172,636,013 |
RGD:6480464 |
CTD |
| G |
FASLG |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
1 |
172,628,185 |
172,636,013 |
RGD:6480464 |
CTD |
| G |
FDPS |
farnesyl diphosphate synthase |
|
increases expression |
ISO |
1 |
155,278,539 |
155,290,457 |
RGD:6480464 |
CTD |
| G |
FGF2 |
fibroblast growth factor 2 (basic) |
|
decreases expression |
ISO |
4 |
123,747,863 |
123,819,390 |
RGD:6480464 |
CTD |
| G |
FGFBP1 |
fibroblast growth factor binding protein 1 |
|
multiple interactions |
ISO |
4 |
15,937,192 |
15,940,363 |
RGD:6480464 |
CTD |
| G |
FGFBP1 |
fibroblast growth factor binding protein 1 |
|
affects expression |
ISO |
4 |
15,937,192 |
15,940,363 |
RGD:6480464 |
CTD |
| G |
FGFR1 |
fibroblast growth factor receptor 1 |
|
decreases expression |
ISO |
8 |
38,268,656 |
38,326,352 |
RGD:6480464 |
CTD |
| G |
FGL1 |
fibrinogen-like 1 |
|
multiple interactions |
ISO |
8 |
17,721,900 |
17,753,047 |
RGD:6480464 |
CTD |
| G |
FGL1 |
fibrinogen-like 1 |
|
increases expression |
ISO |
8 |
17,721,900 |
17,753,047 |
RGD:6480464 |
CTD |
| G |
FKBP4 |
FK506 binding protein 4, 59kDa |
|
decreases expression |
ISO |
12 |
2,904,108 |
2,914,589 |
RGD:6480464 |
CTD |
| G |
FMOD |
fibromodulin |
|
increases expression |
ISO |
1 |
203,309,752 |
203,320,289 |
RGD:6480464 |
CTD |
| G |
FNTA |
farnesyltransferase, CAAX box, alpha |
|
increases expression |
ISO |
8 |
42,911,442 |
42,940,931 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
decreases expression |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOSL1 |
FOS-like antigen 1 |
|
multiple interactions |
ISO |
11 |
65,659,692 |
65,667,997 |
RGD:6480464 |
CTD |
| G |
FOSL1 |
FOS-like antigen 1 |
|
increases expression |
ISO |
11 |
65,659,692 |
65,667,997 |
RGD:6480464 |
CTD |
| G |
FOXA1 |
forkhead box A1 |
|
decreases expression |
EXP |
14 |
38,058,757 |
38,064,325 |
RGD:6480464 |
CTD |
| G |
FOXE3 |
forkhead box E3 |
|
increases expression |
ISO |
1 |
47,881,744 |
47,883,724 |
RGD:6480464 |
CTD |
| G |
FSTL1 |
follistatin-like 1 |
|
multiple interactions |
ISO |
3 |
120,113,061 |
120,169,918 |
RGD:6480464 |
CTD |
| G |
FSTL1 |
follistatin-like 1 |
|
increases expression |
ISO |
3 |
120,113,061 |
120,169,918 |
RGD:6480464 |
CTD |
| G |
FXYD6 |
FXYD domain containing ion transport regulator 6 |
|
increases expression |
ISO |
11 |
117,707,691 |
117,748,201 |
RGD:6480464 |
CTD |
| G |
GABRR3 |
gamma-aminobutyric acid (GABA) A receptor, rho 3 |
|
increases expression |
ISO |
3 |
97,705,527 |
97,754,148 |
RGD:6480464 |
CTD |
| G |
GADD45A |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
1 |
68,150,860 |
68,154,021 |
RGD:6480464 |
CTD |
| G |
GAL |
galanin/GMAP prepropeptide |
|
increases expression |
ISO |
11 |
68,451,983 |
68,458,643 |
RGD:6480464 |
CTD |
| G |
GAL |
galanin/GMAP prepropeptide |
|
multiple interactions |
ISO |
11 |
68,451,983 |
68,458,643 |
RGD:6480464 |
CTD |
| G |
GAL |
galanin/GMAP prepropeptide |
|
increases expression |
ISO |
11 |
68,451,983 |
68,458,643 |
RGD:6480464 |
CTD |
| G |
GAL |
galanin/GMAP prepropeptide |
|
decreases response to substance |
ISO |
11 |
68,451,983 |
68,458,643 |
RGD:6480464 |
CTD |
| G |
GALR2 |
galanin receptor 2 |
|
increases expression |
ISO |
17 |
74,070,892 |
74,073,573 |
RGD:6480464 |
CTD |
| G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
|
multiple interactions |
ISO |
12 |
6,643,585 |
6,647,537 |
RGD:6480464 |
CTD |
| G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
|
increases expression |
EXP |
12 |
6,643,585 |
6,647,537 |
RGD:6480464 |
CTD |
| G |
GAST |
gastrin |
|
decreases secretion |
ISO |
17 |
39,868,578 |
39,872,221 |
RGD:6480464 |
CTD |
| G |
GAST |
gastrin |
|
increases secretion |
ISO |
17 |
39,868,578 |
39,872,221 |
RGD:6480464 |
CTD |
| G |
GAST |
gastrin |
|
decreases secretion |
ISO |
17 |
39,868,578 |
39,872,221 |
RGD:6480464 |
CTD |
| G |
GATA1 |
GATA binding protein 1 (globin transcription factor 1) |
|
increases expression |
ISO |
X |
48,644,982 |
48,652,718 |
RGD:6480464 |
CTD |
| G |
GCG |
glucagon |
|
multiple interactions |
ISO |
2 |
162,999,379 |
163,008,914 |
RGD:6480464 |
CTD |
| G |
GCH1 |
GTP cyclohydrolase 1 |
|
affects response to substance |
EXP |
14 |
55,308,723 |
55,369,542 |
RGD:6480464 |
CTD |
| G |
GDF15 |
growth differentiation factor 15 |
|
multiple interactions |
EXP |
19 |
18,496,968 |
18,499,986 |
RGD:6480464 |
CTD |
| G |
GDF15 |
growth differentiation factor 15 |
|
multiple interactions |
EXP |
19 |
18,496,968 |
18,499,986 |
RGD:6480464 |
CTD |
| G |
GDF15 |
growth differentiation factor 15 |
|
increases expression |
EXP |
19 |
18,496,968 |
18,499,986 |
RGD:6480464 |
CTD |
| G |
GDF15 |
growth differentiation factor 15 |
|
increases phosphorylation |
EXP |
19 |
18,496,968 |
18,499,986 |
RGD:6480464 |
CTD |
| G |
GFAP |
glial fibrillary acidic protein |
|
increases expression |
EXP |
17 |
42,982,994 |
42,992,920 |
RGD:6480464 |
CTD |
| G |
GFAP |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
17 |
42,982,994 |
42,992,920 |
RGD:6480464 |
CTD |
| G |
GFRA1 |
GDNF family receptor alpha 1 |
|
affects expression |
ISO |
10 |
117,816,436 |
118,033,126 |
RGD:6480464 |
CTD |
| G |
GFRA1 |
GDNF family receptor alpha 1 |
|
multiple interactions |
ISO |
10 |
117,816,436 |
118,033,126 |
RGD:6480464 |
CTD |
| G |
GFRA2 |
GDNF family receptor alpha 2 |
|
affects expression |
ISO |
8 |
21,549,530 |
21,646,346 |
RGD:6480464 |
CTD |
| G |
GFRA2 |
GDNF family receptor alpha 2 |
|
multiple interactions |
ISO |
8 |
21,549,530 |
21,646,346 |
RGD:6480464 |
CTD |
| G |
GH1 |
growth hormone 1 |
|
increases expression |
ISO |
17 |
61,994,563 |
61,996,198 |
RGD:6480464 |
CTD |
| G |
GH1 |
growth hormone 1 |
|
multiple interactions |
ISO |
17 |
61,994,563 |
61,996,198 |
RGD:6480464 |
CTD |
| G |
GH1 |
growth hormone 1 |
|
decreases secretion |
ISO |
17 |
61,994,563 |
61,996,198 |
RGD:6480464 |
CTD |
| G |
GHR |
growth hormone receptor |
|
increases expression |
ISO |
5 |
42,423,877 |
42,721,980 |
RGD:6480464 |
CTD |
| G |
GHR |
growth hormone receptor |
|
multiple interactions |
ISO |
5 |
42,423,877 |
42,721,980 |
RGD:6480464 |
CTD |
| G |
GHRL |
ghrelin/obestatin prepropeptide |
|
multiple interactions |
ISO |
3 |
10,327,434 |
10,334,631 |
RGD:6480464 |
CTD |
| G |
GHRL |
ghrelin/obestatin prepropeptide |
|
decreases activity |
ISO |
3 |
10,327,434 |
10,334,631 |
RGD:6480464 |
CTD |
| G |
GHRL |
ghrelin/obestatin prepropeptide |
|
multiple interactions |
ISO |
3 |
10,327,434 |
10,334,631 |
RGD:6480464 |
CTD |
| G |
GJB6 |
gap junction protein, beta 6, 30kDa |
|
increases expression |
ISO |
13 |
20,796,101 |
20,806,534 |
RGD:6480464 |
CTD |
| G |
GLP1R |
glucagon-like peptide 1 receptor |
|
decreases expression |
ISO |
6 |
39,016,557 |
39,055,520 |
RGD:6480464 |
CTD |
| G |
GLUD1 |
glutamate dehydrogenase 1 |
|
increases expression |
EXP |
10 |
88,809,959 |
88,854,776 |
RGD:6480464 |
CTD |
| G |
GOT1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
multiple interactions |
ISO |
10 |
101,156,627 |
101,190,530 |
RGD:6480464 |
CTD |
| G |
GPR132 |
G protein-coupled receptor 132 |
|
decreases expression |
ISO |
14 |
105,515,737 |
105,531,754 |
RGD:6480464 |
CTD |
| G |
GPR176 |
G protein-coupled receptor 176 |
|
decreases expression |
ISO |
15 |
40,092,931 |
40,213,093 |
RGD:6480464 |
CTD |
| G |
GPR4 |
G protein-coupled receptor 4 |
|
decreases expression |
ISO |
19 |
46,093,022 |
46,105,466 |
RGD:6480464 |
CTD |
| G |
GPT |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
ISO |
8 |
145,729,465 |
145,732,555 |
RGD:6480464 |
CTD |
| G |
GPX1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
3 |
49,394,609 |
49,395,791 |
RGD:6480464 |
CTD |
| G |
GPX4 |
glutathione peroxidase 4 |
|
multiple interactions |
ISO |
19 |
1,103,936 |
1,106,787 |
RGD:6480464 |
CTD |
| G |
GRIA1 |
glutamate receptor, ionotropic, AMPA 1 |
|
increases phosphorylation |
ISO |
5 |
152,870,084 |
153,193,429 |
RGD:6480464 |
CTD |
| G |
GRIA1 |
glutamate receptor, ionotropic, AMPA 1 |
|
multiple interactions |
ISO |
5 |
152,870,084 |
153,193,429 |
RGD:6480464 |
CTD |
| G |
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
multiple interactions |
ISO |
9 |
140,033,609 |
140,063,214 |
RGD:6480464 |
CTD |
| G |
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
increases expression |
ISO |
9 |
140,033,609 |
140,063,214 |
RGD:6480464 |
CTD |
| G |
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
increases phosphorylation |
ISO |
9 |
140,033,609 |
140,063,214 |
RGD:6480464 |
CTD |
| G |
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
multiple interactions |
ISO |
9 |
140,033,609 |
140,063,214 |
RGD:6480464 |
CTD |
| G |
GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
increases phosphorylation |
ISO |
12 |
13,714,410 |
14,133,022 |
RGD:6480464 |
CTD |
| G |
GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
ISO |
12 |
13,714,410 |
14,133,022 |
RGD:6480464 |
CTD |
| G |
GRK6 |
G protein-coupled receptor kinase 6 |
|
multiple interactions |
ISO |
5 |
176,853,687 |
176,869,850 |
RGD:6480464 |
CTD |
| G |
GRK6 |
G protein-coupled receptor kinase 6 |
|
decreases response to substance |
ISO |
5 |
176,853,687 |
176,869,850 |
RGD:6480464 |
CTD |
| G |
GSK3B |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
3 |
119,540,800 |
119,813,264 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSTP1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
11 |
67,351,066 |
67,354,124 |
RGD:6480464 |
CTD |
| G |
GTF2H2 |
general transcription factor IIH, polypeptide 2, 44kDa |
|
decreases expression |
ISO |
5 |
70,330,951 |
70,363,497 |
RGD:6480464 |
CTD |
| G |
GYPA |
glycophorin A (MNS blood group) |
|
increases expression |
ISO |
4 |
145,030,456 |
145,061,904 |
RGD:6480464 |
CTD |
| G |
GZMA |
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
|
multiple interactions |
EXP |
5 |
54,398,474 |
54,406,080 |
RGD:6480464 |
CTD |
| G |
GZMA |
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
|
increases expression |
EXP |
5 |
54,398,474 |
54,406,080 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
increases localization |
EXP |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
H6PD |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
|
multiple interactions |
ISO |
1 |
9,294,863 |
9,331,396 |
RGD:6480464 |
CTD |
| G |
HBEGF |
heparin-binding EGF-like growth factor |
|
multiple interactions |
ISO |
5 |
139,712,428 |
139,726,188 |
RGD:6480464 |
CTD |
| G |
HBG1 |
hemoglobin, gamma A |
|
multiple interactions |
ISO |
11 |
5,269,502 |
5,271,087 |
RGD:6480464 |
CTD |
| G |
HCRT |
hypocretin (orexin) neuropeptide precursor |
|
multiple interactions |
ISO |
17 |
40,336,078 |
40,337,470 |
RGD:6480464 |
CTD |
| G |
HCRT |
hypocretin (orexin) neuropeptide precursor |
|
increases expression |
ISO |
17 |
40,336,078 |
40,337,470 |
RGD:6480464 |
CTD |
| G |
HDAC2 |
histone deacetylase 2 |
|
increases expression |
ISO |
6 |
114,257,320 |
114,292,359 |
RGD:6480464 |
CTD |
| G |
HEY2 |
hairy/enhancer-of-split related with YRPW motif 2 |
|
increases expression |
ISO |
6 |
126,070,732 |
126,082,415 |
RGD:6480464 |
CTD |
| G |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression |
EXP |
14 |
62,162,119 |
62,214,977 |
RGD:6480464 |
CTD |
| G |
HIP1R |
huntingtin interacting protein 1 related |
|
decreases expression |
ISO |
12 |
123,320,039 |
123,347,507 |
RGD:6480464 |
CTD |
| G |
HIST1H2BA |
histone cluster 1, H2ba |
|
decreases expression |
ISO |
6 |
25,727,137 |
25,727,573 |
RGD:6480464 |
CTD |
| G |
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
|
multiple interactions |
ISO |
6 |
32,627,241 |
32,634,466 |
RGD:6480464 |
CTD |
| G |
HMGB2 |
high mobility group box 2 |
|
increases expression |
ISO |
4 |
174,252,527 |
174,255,595 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HNRNPA1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
increases expression |
ISO |
12 |
54,674,488 |
54,679,030 |
RGD:6480464 |
CTD |
| G |
HPCAL1 |
hippocalcin-like 1 |
|
increases expression |
ISO |
2 |
10,443,030 |
10,567,743 |
RGD:6480464 |
CTD |
| G |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
increases expression |
EXP |
11 |
532,242 |
535,550 |
RGD:6480464 |
CTD |
| G |
HSP90B1 |
heat shock protein 90kDa beta (Grp94), member 1 |
|
multiple interactions |
ISO |
12 |
104,324,112 |
104,341,708 |
RGD:6480464 |
CTD |
| G |
HSP90B1 |
heat shock protein 90kDa beta (Grp94), member 1 |
|
increases expression |
EXP |
12 |
104,324,112 |
104,341,708 |
RGD:6480464 |
CTD |
| G |
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
increases expression |
EXP |
9 |
127,997,127 |
128,003,666 |
RGD:6480464 |
CTD |
| G |
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
increases expression |
EXP |
9 |
127,997,127 |
128,003,666 |
RGD:6480464 |
CTD |
| G |
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
increases localization |
EXP |
9 |
127,997,127 |
128,003,666 |
RGD:6480464 |
CTD |
| G |
HTR1B |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
multiple interactions |
ISO |
6 |
78,171,948 |
78,173,120 |
RGD:6480464 |
CTD |
| G |
HTR1D |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
|
multiple interactions |
ISO |
1 |
23,518,388 |
23,521,222 |
RGD:6480464 |
CTD |
| G |
HTR1F |
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
|
multiple interactions |
ISO |
3 |
88,031,726 |
88,042,919 |
RGD:6480464 |
CTD |
| G |
HTR3B |
5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
|
decreases expression |
ISO |
11 |
113,775,518 |
113,817,283 |
RGD:6480464 |
CTD |
| G |
ICAM1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
19 |
10,381,517 |
10,397,291 |
RGD:6480464 |
CTD |
| G |
ICK |
intestinal cell (MAK-like) kinase |
|
increases expression |
ISO |
6 |
52,866,098 |
52,926,600 |
RGD:6480464 |
CTD |
| G |
ICK |
intestinal cell (MAK-like) kinase |
|
multiple interactions |
ISO |
6 |
52,866,098 |
52,926,600 |
RGD:6480464 |
CTD |
| G |
IDE |
insulin-degrading enzyme |
|
multiple interactions |
ISO |
10 |
94,211,441 |
94,333,852 |
RGD:6480464 |
CTD |
| G |
IDE |
insulin-degrading enzyme |
|
affects expression |
ISO |
10 |
94,211,441 |
94,333,852 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
decreases expression |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
decreases expression |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
increases expression |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
increases expression |
EXP |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
multiple interactions |
EXP |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
increases expression |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
multiple interactions |
EXP |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
multiple interactions |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
multiple interactions |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
increases expression |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
increases expression |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
increases expression |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
multiple interactions |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1R |
insulin-like growth factor 1 receptor |
|
increases expression |
EXP |
15 |
99,192,761 |
99,507,759 |
RGD:6480464 |
CTD |
| G |
IGF1R |
insulin-like growth factor 1 receptor |
|
multiple interactions |
EXP |
15 |
99,192,761 |
99,507,759 |
RGD:6480464 |
CTD |
| G |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
|
increases expression |
ISO |
11 |
2,150,347 |
2,170,833 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
increases expression |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
increases expression |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL11RA |
interleukin 11 receptor, alpha |
|
decreases expression |
ISO |
9 |
34,652,182 |
34,661,899 |
RGD:6480464 |
CTD |
| G |
IL12B |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
decreases expression |
EXP |
5 |
158,741,791 |
158,757,481 |
RGD:6480464 |
CTD |
| G |
IL13 |
interleukin 13 |
|
multiple interactions |
ISO |
5 |
131,993,865 |
131,996,801 |
RGD:6480464 |
CTD |
| G |
IL13 |
interleukin 13 |
|
increases expression |
ISO |
5 |
131,993,865 |
131,996,801 |
RGD:6480464 |
CTD |
| G |
IL1A |
interleukin 1, alpha |
|
multiple interactions |
ISO |
2 |
113,531,492 |
113,542,971 |
RGD:6480464 |
CTD |
| G |
IL1A |
interleukin 1, alpha |
|
decreases expression |
ISO |
2 |
113,531,492 |
113,542,971 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
affects expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
decreases secretion |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
decreases expression |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
increases expression |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL3 |
interleukin 3 (colony-stimulating factor, multiple) |
|
multiple interactions |
ISO |
5 |
131,396,347 |
131,398,896 |
RGD:6480464 |
CTD |
| G |
IL3 |
interleukin 3 (colony-stimulating factor, multiple) |
|
affects expression |
ISO |
5 |
131,396,347 |
131,398,896 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
decreases expression |
ISO |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
multiple interactions |
ISO |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL4 |
interleukin 4 |
|
increases expression |
ISO |
5 |
132,009,678 |
132,018,370 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
decreases expression |
ISO |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
increases expression |
ISO |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
multiple interactions |
ISO |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases expression |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases secretion |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases expression |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
decreases secretion |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
decreases expression |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
decreases expression |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases expression |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases expression |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL7 |
interleukin 7 |
|
decreases expression |
ISO |
8 |
79,645,007 |
79,717,758 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
affects expression |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
decreases expression |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
increases expression |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
increases secretion |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
INHBA |
inhibin, beta A |
|
increases expression |
ISO |
7 |
41,728,601 |
41,742,706 |
RGD:6480464 |
CTD |
| G |
INHBA |
inhibin, beta A |
|
multiple interactions |
ISO |
7 |
41,728,601 |
41,742,706 |
RGD:6480464 |
CTD |
| G |
IRS1 |
insulin receptor substrate 1 |
|
increases expression |
ISO |
2 |
227,596,033 |
227,663,506 |
RGD:6480464 |
CTD |
| G |
ITGA5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
increases expression |
ISO |
12 |
54,789,045 |
54,813,050 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
increases expression |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUND |
jun D proto-oncogene |
|
increases expression |
ISO |
19 |
18,390,563 |
18,392,432 |
RGD:6480464 |
CTD |
| G |
KCNQ4 |
potassium voltage-gated channel, KQT-like subfamily, member 4 |
|
increases expression |
ISO |
1 |
41,249,684 |
41,306,124 |
RGD:6480464 |
CTD |
| G |
KIAA0101 |
KIAA0101 |
|
increases expression |
ISO |
15 |
64,657,193 |
64,673,702 |
RGD:6480464 |
CTD |
| G |
KIF11 |
kinesin family member 11 |
|
increases expression |
ISO |
10 |
94,352,825 |
94,415,152 |
RGD:6480464 |
CTD |
| G |
KLF4 |
Kruppel-like factor 4 (gut) |
|
increases expression |
ISO |
9 |
110,247,133 |
110,252,047 |
RGD:6480464 |
CTD |
| G |
KLK3 |
kallikrein-related peptidase 3 |
|
multiple interactions |
EXP |
19 |
51,358,171 |
51,364,020 |
RGD:6480464 |
CTD |
| G |
KLK6 |
kallikrein-related peptidase 6 |
|
increases expression |
ISO |
19 |
51,461,887 |
51,472,929 |
RGD:6480464 |
CTD |
| G |
KNG1 |
kininogen 1 |
|
multiple interactions |
ISO |
3 |
186,435,098 |
186,462,199 |
RGD:6480464 |
CTD |
| G |
KNG1 |
kininogen 1 |
|
multiple interactions |
ISO |
3 |
186,435,098 |
186,462,199 |
RGD:6480464 |
CTD |
| G |
KNG1 |
kininogen 1 |
|
multiple interactions |
ISO |
3 |
186,435,098 |
186,462,199 |
RGD:6480464 |
CTD |
| G |
KNG1 |
kininogen 1 |
|
increases response to substance |
ISO |
3 |
186,435,098 |
186,462,199 |
RGD:6480464 |
CTD |
| G |
LEP |
leptin |
|
decreases expression |
ISO |
7 |
127,881,331 |
127,897,682 |
RGD:6480464 |
CTD |
| G |
LEP |
leptin |
|
increases expression |
ISO |
7 |
127,881,331 |
127,897,682 |
RGD:6480464 |
CTD |
| G |
LEP |
leptin |
|
increases expression |
ISO |
7 |
127,881,331 |
127,897,682 |
RGD:6480464 |
CTD |
| G |
LEP |
leptin |
|
multiple interactions |
ISO |
7 |
127,881,331 |
127,897,682 |
RGD:6480464 |
CTD |
| G |
LEP |
leptin |
|
multiple interactions |
ISO |
7 |
127,881,331 |
127,897,682 |
RGD:6480464 |
CTD |
| G |
LRP1 |
low density lipoprotein receptor-related protein 1 |
|
multiple interactions |
ISO |
12 |
57,522,282 |
57,607,142 |
RGD:6480464 |
CTD |
| G |
LRP1 |
low density lipoprotein receptor-related protein 1 |
|
decreases expression |
ISO |
12 |
57,522,282 |
57,607,142 |
RGD:6480464 |
CTD |
| G |
LRP1 |
low density lipoprotein receptor-related protein 1 |
|
decreases response to substance |
ISO |
12 |
57,522,282 |
57,607,142 |
RGD:6480464 |
CTD |
| G |
LTB4R2 |
leukotriene B4 receptor 2 |
|
decreases expression |
ISO |
14 |
24,779,357 |
24,781,259 |
RGD:6480464 |
CTD |
| G |
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7 |
|
multiple interactions |
EXP |
6 |
91,223,292 |
91,297,020 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
EXP |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK7 |
mitogen-activated protein kinase 7 |
|
increases phosphorylation |
ISO |
17 |
19,281,034 |
19,286,857 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
increases activity |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
increases activity |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
5 |
179,660,594 |
179,719,071 |
RGD:6480464 |
CTD |
| G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
5 |
179,660,594 |
179,719,071 |
RGD:6480464 |
CTD |
| G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
EXP |
5 |
179,660,594 |
179,719,071 |
RGD:6480464 |
CTD |
| G |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
|
increases expression |
ISO |
6 |
114,178,527 |
114,184,652 |
RGD:6480464 |
CTD |
| G |
MDH1 |
malate dehydrogenase 1, NAD (soluble) |
|
multiple interactions |
ISO |
2 |
63,815,743 |
63,834,331 |
RGD:6480464 |
CTD |
| G |
MDM2 |
MDM2 oncogene, E3 ubiquitin protein ligase |
|
multiple interactions |
EXP |
12 |
69,201,971 |
69,239,320 |
RGD:6480464 |
CTD |
| G |
MDM2 |
MDM2 oncogene, E3 ubiquitin protein ligase |
|
decreases expression |
EXP |
12 |
69,201,971 |
69,239,320 |
RGD:6480464 |
CTD |
| G |
MIF |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
increases expression |
ISO |
22 |
24,236,565 |
24,237,409 |
RGD:6480464 |
CTD |
| G |
MIF |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
multiple interactions |
ISO |
22 |
24,236,565 |
24,237,409 |
RGD:6480464 |
CTD |
| G |
MMP1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
increases expression |
EXP |
11 |
102,660,641 |
102,668,966 |
RGD:6480464 |
CTD |
| G |
MMP13 |
matrix metallopeptidase 13 (collagenase 3) |
|
decreases expression |
ISO |
11 |
102,813,721 |
102,826,463 |
RGD:6480464 |
CTD |
| G |
MMP13 |
matrix metallopeptidase 13 (collagenase 3) |
|
increases expression |
ISO |
11 |
102,813,721 |
102,826,463 |
RGD:6480464 |
CTD |
| G |
MMP13 |
matrix metallopeptidase 13 (collagenase 3) |
|
multiple interactions |
ISO |
11 |
102,813,721 |
102,826,463 |
RGD:6480464 |
CTD |
| G |
MMP14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
multiple interactions |
EXP |
14 |
23,305,793 |
23,316,803 |
RGD:6480464 |
CTD |
| G |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
|
multiple interactions |
EXP |
16 |
55,513,081 |
55,540,586 |
RGD:6480464 |
CTD |
| G |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
|
multiple interactions |
ISO |
16 |
55,513,081 |
55,540,586 |
RGD:6480464 |
CTD |
| G |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
|
increases expression |
ISO |
16 |
55,513,081 |
55,540,586 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
increases expression |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MOBP |
myelin-associated oligodendrocyte basic protein |
|
increases expression |
ISO |
3 |
39,509,070 |
39,567,859 |
RGD:6480464 |
CTD |
| G |
MOG |
myelin oligodendrocyte glycoprotein |
|
increases expression |
ISO |
6 |
29,624,758 |
29,640,149 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
affects activity |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
decreases expression |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MRPL3 |
mitochondrial ribosomal protein L3 |
|
decreases expression |
ISO |
3 |
131,181,045 |
131,221,860 |
RGD:6480464 |
CTD |
| G |
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases phosphorylation |
EXP |
1 |
11,166,588 |
11,322,608 |
RGD:6480464 |
CTD |
| G |
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
EXP |
1 |
11,166,588 |
11,322,608 |
RGD:6480464 |
CTD |
| G |
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
|
increases phosphorylation |
EXP |
1 |
11,166,588 |
11,322,608 |
RGD:6480464 |
CTD |
| G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
|
increases secretion |
EXP |
11 |
1,244,295 |
1,283,406 |
RGD:6480464 |
CTD |
| G |
MUSK |
muscle, skeletal, receptor tyrosine kinase |
|
multiple interactions |
ISO |
9 |
113,431,051 |
113,563,278 |
RGD:6480464 |
CTD |
| G |
MUSK |
muscle, skeletal, receptor tyrosine kinase |
|
increases expression |
ISO |
9 |
113,431,051 |
113,563,278 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
increases expression |
EXP |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYL1 |
myosin, light chain 1, alkali; skeletal, fast |
|
multiple interactions |
ISO |
2 |
211,154,868 |
211,179,895 |
RGD:6480464 |
CTD |
| G |
NCR1 |
natural cytotoxicity triggering receptor 1 |
|
increases expression |
ISO |
19 |
55,417,508 |
55,424,439 |
RGD:6480464 |
CTD |
| G |
NDUFB4 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa |
|
decreases expression |
ISO |
3 |
120,315,128 |
120,321,258 |
RGD:6480464 |
CTD |
| G |
NDUFB4 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa |
|
decreases expression |
ISO |
3 |
120,315,128 |
120,321,258 |
RGD:6480464 |
CTD |
| G |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
|
increases localization |
ISO |
14 |
24,836,145 |
24,848,810 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
increases localization |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases degradation |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases phosphorylation |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases localization |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
EXP |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
decreases expression |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
increases expression |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
increases response to substance |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
increases response to substance |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
decreases expression |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
increases expression |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
increases response to substance |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NGFR |
nerve growth factor receptor |
|
increases expression |
ISO |
17 |
47,572,655 |
47,592,382 |
RGD:6480464 |
CTD |
| G |
NGFR |
nerve growth factor receptor |
|
decreases expression |
ISO |
17 |
47,572,655 |
47,592,382 |
RGD:6480464 |
CTD |
| G |
NGFR |
nerve growth factor receptor |
|
multiple interactions |
ISO |
17 |
47,572,655 |
47,592,382 |
RGD:6480464 |
CTD |
| G |
NME2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
increases expression |
EXP |
17 |
49,242,796 |
49,249,105 |
RGD:6480464 |
CTD |
| G |
NOS1 |
nitric oxide synthase 1 (neuronal) |
|
increases expression |
ISO |
12 |
117,645,947 |
117,799,607 |
RGD:6480464 |
CTD |
| G |
NOS1 |
nitric oxide synthase 1 (neuronal) |
|
increases expression |
EXP |
12 |
117,645,947 |
117,799,607 |
RGD:6480464 |
CTD |
| G |
NOS1 |
nitric oxide synthase 1 (neuronal) |
|
multiple interactions |
EXP |
12 |
117,645,947 |
117,799,607 |
RGD:6480464 |
CTD |
| G |
NOS1 |
nitric oxide synthase 1 (neuronal) |
|
increases expression |
ISO |
12 |
117,645,947 |
117,799,607 |
RGD:6480464 |
CTD |
| G |
NOS1 |
nitric oxide synthase 1 (neuronal) |
|
increases expression |
ISO |
12 |
117,645,947 |
117,799,607 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
|
multiple interactions |
EXP |
7 |
150,688,144 |
150,711,687 |
RGD:6480464 |
CTD |
| G |
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
|
increases expression |
EXP |
7 |
150,688,144 |
150,711,687 |
RGD:6480464 |
CTD |
| G |
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
|
decreases expression |
ISO |
7 |
150,688,144 |
150,711,687 |
RGD:6480464 |
CTD |
| G |
NOX3 |
NADPH oxidase 3 |
|
multiple interactions |
ISO |
6 |
155,716,502 |
155,777,037 |
RGD:6480464 |
CTD |
| G |
NPY1R |
neuropeptide Y receptor Y1 |
|
increases response to substance |
ISO |
4 |
164,245,117 |
164,253,947 |
RGD:6480464 |
CTD |
| G |
NQO1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
16 |
69,743,304 |
69,760,533 |
RGD:6480464 |
CTD |
| G |
NQO1 |
NAD(P)H dehydrogenase, quinone 1 |
|
decreases expression |
EXP |
16 |
69,743,304 |
69,760,533 |
RGD:6480464 |
CTD |
| G |
NQO1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
16 |
69,743,304 |
69,760,533 |
RGD:6480464 |
CTD |
| G |
NQO2 |
NAD(P)H dehydrogenase, quinone 2 |
|
multiple interactions |
ISO |
6 |
3,000,067 |
3,019,994 |
RGD:6480464 |
CTD |
| G |
NRP1 |
neuropilin 1 |
|
increases expression |
ISO |
10 |
33,466,419 |
33,623,833 |
RGD:6480464 |
CTD |
| G |
NRP1 |
neuropilin 1 |
|
multiple interactions |
ISO |
10 |
33,466,419 |
33,623,833 |
RGD:6480464 |
CTD |
| G |
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
multiple interactions |
EXP |
1 |
156,785,542 |
156,851,642 |
RGD:6480464 |
CTD |
| G |
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
decreases expression |
ISO |
1 |
156,785,542 |
156,851,642 |
RGD:6480464 |
CTD |
| G |
OGDH |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
|
multiple interactions |
ISO |
7 |
44,646,121 |
44,748,669 |
RGD:6480464 |
CTD |
| G |
OLIG1 |
oligodendrocyte transcription factor 1 |
|
increases expression |
ISO |
21 |
34,442,450 |
34,444,728 |
RGD:6480464 |
CTD |
| G |
OPRL1 |
opiate receptor-like 1 |
|
multiple interactions |
ISO |
20 |
62,711,471 |
62,731,996 |
RGD:6480464 |
CTD |
| G |
OPRM1 |
opioid receptor, mu 1 |
|
multiple interactions |
EXP |
6 |
154,331,631 |
154,568,001 |
RGD:6480464 |
CTD |
| G |
P2RY2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
affects response to substance |
ISO |
11 |
72,929,344 |
72,947,397 |
RGD:6480464 |
CTD |
| G |
P2RY2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
multiple interactions |
ISO |
11 |
72,929,344 |
72,947,397 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
increases ADP-ribosylation |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
increases expression |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PCOLCE |
procollagen C-endopeptidase enhancer |
|
increases expression |
ISO |
7 |
100,199,882 |
100,205,798 |
RGD:6480464 |
CTD |
| G |
PCSK5 |
proprotein convertase subtilisin/kexin type 5 |
|
decreases expression |
ISO |
9 |
78,505,560 |
78,977,255 |
RGD:6480464 |
CTD |
| G |
PCTP |
phosphatidylcholine transfer protein |
|
decreases expression |
EXP |
17 |
53,828,340 |
53,854,748 |
RGD:6480464 |
CTD |
| G |
PDE2A |
phosphodiesterase 2A, cGMP-stimulated |
|
decreases expression |
ISO |
11 |
72,287,184 |
72,385,497 |
RGD:6480464 |
CTD |
| G |
PDGFA |
platelet-derived growth factor alpha polypeptide |
|
increases expression |
ISO |
7 |
536,895 |
559,481 |
RGD:6480464 |
CTD |
| G |
PDGFA |
platelet-derived growth factor alpha polypeptide |
|
multiple interactions |
ISO |
7 |
536,895 |
559,481 |
RGD:6480464 |
CTD |
| G |
PDX1 |
pancreatic and duodenal homeobox 1 |
|
decreases expression |
ISO |
13 |
28,494,168 |
28,500,451 |
RGD:6480464 |
CTD |
| G |
PDYN |
prodynorphin |
|
increases expression |
ISO |
20 |
1,959,402 |
1,974,931 |
RGD:6480464 |
CTD |
| G |
PDYN |
prodynorphin |
|
multiple interactions |
ISO |
20 |
1,959,402 |
1,974,931 |
RGD:6480464 |
CTD |
| G |
PDZD2 |
PDZ domain containing 2 |
|
increases expression |
ISO |
5 |
31,799,031 |
32,111,038 |
RGD:6480464 |
CTD |
| G |
PGM1 |
phosphoglucomutase 1 |
|
increases expression |
EXP |
1 |
64,058,947 |
64,125,916 |
RGD:6480464 |
CTD |
| G |
PGM1 |
phosphoglucomutase 1 |
|
decreases expression |
ISO |
1 |
64,058,947 |
64,125,916 |
RGD:6480464 |
CTD |
| G |
PHB2 |
prohibitin 2 |
|
multiple interactions |
EXP |
12 |
7,074,515 |
7,079,916 |
RGD:6480464 |
CTD |
| G |
PHOX2A |
paired-like homeobox 2a |
|
increases expression |
ISO |
11 |
71,950,121 |
71,955,220 |
RGD:6480464 |
CTD |
| G |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
multiple interactions |
ISO |
5 |
67,511,584 |
67,597,649 |
RGD:6480464 |
CTD |
| G |
PLA2G15 |
phospholipase A2, group XV |
|
decreases expression |
ISO |
16 |
68,279,247 |
68,294,961 |
RGD:6480464 |
CTD |
| G |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
multiple interactions |
EXP |
1 |
186,798,032 |
186,958,113 |
RGD:6480464 |
CTD |
| G |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases phosphorylation |
EXP |
1 |
186,798,032 |
186,958,113 |
RGD:6480464 |
CTD |
| G |
PLAU |
plasminogen activator, urokinase |
|
increases expression |
EXP |
10 |
75,670,862 |
75,677,259 |
RGD:6480464 |
CTD |
| G |
PLAUR |
plasminogen activator, urokinase receptor |
|
increases expression |
EXP |
19 |
44,150,247 |
44,174,498 |
RGD:6480464 |
CTD |
| G |
PLCB3 |
phospholipase C, beta 3 (phosphatidylinositol-specific) |
|
decreases expression |
ISO |
11 |
64,018,995 |
64,036,924 |
RGD:6480464 |
CTD |
| G |
PLIN2 |
perilipin 2 |
|
affects expression |
ISO |
9 |
19,115,759 |
19,127,604 |
RGD:6480464 |
CTD |
| G |
PLIN2 |
perilipin 2 |
|
multiple interactions |
ISO |
9 |
19,115,759 |
19,127,604 |
RGD:6480464 |
CTD |
| G |
PLP1 |
proteolipid protein 1 |
|
increases expression |
ISO |
X |
103,031,439 |
103,047,548 |
RGD:6480464 |
CTD |
| G |
PNISR |
PNN-interacting serine/arginine-rich protein |
|
increases expression |
ISO |
6 |
99,847,840 |
99,873,207 |
RGD:6480464 |
CTD |
| G |
POLB |
polymerase (DNA directed), beta |
|
decreases expression |
ISO |
8 |
42,195,973 |
42,229,331 |
RGD:6480464 |
CTD |
| G |
POLR2F |
polymerase (RNA) II (DNA directed) polypeptide F |
|
increases expression |
ISO |
22 |
38,349,674 |
38,365,319 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
multiple interactions |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
increases expression |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
multiple interactions |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
increases secretion |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
multiple interactions |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POR |
P450 (cytochrome) oxidoreductase |
|
multiple interactions |
ISO |
7 |
75,544,420 |
75,616,173 |
RGD:6480464 |
CTD |
| G |
PPARA |
peroxisome proliferator-activated receptor alpha |
|
increases expression |
ISO |
22 |
46,546,499 |
46,639,653 |
RGD:6480464 |
CTD |
| G |
PPARA |
peroxisome proliferator-activated receptor alpha |
|
decreases expression |
EXP |
22 |
46,546,499 |
46,639,653 |
RGD:6480464 |
CTD |
| G |
PPARD |
peroxisome proliferator-activated receptor delta |
|
decreases expression |
EXP |
6 |
35,310,335 |
35,395,968 |
RGD:6480464 |
CTD |
| G |
PPARG |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
3 |
12,329,349 |
12,475,855 |
RGD:6480464 |
CTD |
| G |
PPARG |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
3 |
12,329,349 |
12,475,855 |
RGD:6480464 |
CTD |
| G |
PPARG |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
EXP |
3 |
12,329,349 |
12,475,855 |
RGD:6480464 |
CTD |
| G |
PPARG |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
ISO |
3 |
12,329,349 |
12,475,855 |
RGD:6480464 |
CTD |
| G |
PPARG |
peroxisome proliferator-activated receptor gamma |
|
increases activity |
EXP |
3 |
12,329,349 |
12,475,855 |
RGD:6480464 |
CTD |
| G |
PPARGC1A |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
4 |
23,793,644 |
23,891,700 |
RGD:6480464 |
CTD |
| G |
PPARGC1A |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
4 |
23,793,644 |
23,891,700 |
RGD:6480464 |
CTD |
| G |
PPP1R12A |
protein phosphatase 1, regulatory subunit 12A |
|
multiple interactions |
EXP |
12 |
80,167,343 |
80,329,235 |
RGD:6480464 |
CTD |
| G |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
|
multiple interactions |
ISO |
4 |
101,944,587 |
102,268,628 |
RGD:6480464 |
CTD |
| G |
PPP5C |
protein phosphatase 5, catalytic subunit |
|
increases expression |
ISO |
19 |
46,850,251 |
46,894,232 |
RGD:6480464 |
CTD |
| G |
PRDX1 |
peroxiredoxin 1 |
|
multiple interactions |
ISO |
1 |
45,976,707 |
45,988,562 |
RGD:6480464 |
CTD |
| G |
PRDX6 |
peroxiredoxin 6 |
|
increases expression |
EXP |
1 |
173,446,486 |
173,457,946 |
RGD:6480464 |
CTD |
| G |
PRKAA1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
increases expression |
ISO |
5 |
40,759,481 |
40,798,297 |
RGD:6480464 |
CTD |
| G |
PRKAA1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
multiple interactions |
ISO |
5 |
40,759,481 |
40,798,297 |
RGD:6480464 |
CTD |
| G |
PRKAA1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
multiple interactions |
EXP |
5 |
40,759,481 |
40,798,297 |
RGD:6480464 |
CTD |
| G |
PRKACA |
protein kinase, cAMP-dependent, catalytic, alpha |
|
increases phosphorylation |
ISO |
19 |
14,202,500 |
14,228,559 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
multiple interactions |
EXP |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
increases expression |
EXP |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
increases expression |
ISO |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
multiple interactions |
ISO |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
multiple interactions |
EXP |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
increases expression |
EXP |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCE |
protein kinase C, epsilon |
|
multiple interactions |
EXP |
2 |
45,879,043 |
46,415,129 |
RGD:6480464 |
CTD |
| G |
PRKD1 |
protein kinase D1 |
|
multiple interactions |
ISO |
14 |
30,045,685 |
30,396,899 |
RGD:6480464 |
CTD |
| G |
PRKD1 |
protein kinase D1 |
|
multiple interactions |
EXP |
14 |
30,045,685 |
30,396,899 |
RGD:6480464 |
CTD |
| G |
PRKDC |
protein kinase, DNA-activated, catalytic polypeptide |
|
increases phosphorylation |
EXP |
8 |
48,685,669 |
48,872,743 |
RGD:6480464 |
CTD |
| G |
PRKDC |
protein kinase, DNA-activated, catalytic polypeptide |
|
multiple interactions |
EXP |
8 |
48,685,669 |
48,872,743 |
RGD:6480464 |
CTD |
| G |
PRLR |
prolactin receptor |
|
increases expression |
ISO |
5 |
35,048,861 |
35,230,823 |
RGD:6480464 |
CTD |
| G |
PRLR |
prolactin receptor |
|
multiple interactions |
ISO |
5 |
35,048,861 |
35,230,823 |
RGD:6480464 |
CTD |
| G |
PROK1 |
prokineticin 1 |
|
multiple interactions |
ISO |
1 |
110,993,788 |
110,999,976 |
RGD:6480464 |
CTD |
| G |
PROK1 |
prokineticin 1 |
|
increases expression |
ISO |
1 |
110,993,788 |
110,999,976 |
RGD:6480464 |
CTD |
| G |
PROK2 |
prokineticin 2 |
|
increases response to substance |
ISO |
3 |
71,820,806 |
71,834,357 |
RGD:6480464 |
CTD |
| G |
PROKR1 |
prokineticin receptor 1 |
|
multiple interactions |
ISO |
2 |
68,872,954 |
68,882,708 |
RGD:6480464 |
CTD |
| G |
PROKR1 |
prokineticin receptor 1 |
|
increases response to substance |
ISO |
2 |
68,872,954 |
68,882,708 |
RGD:6480464 |
CTD |
| G |
PROKR2 |
prokineticin receptor 2 |
|
decreases expression |
ISO |
20 |
5,282,686 |
5,295,015 |
RGD:6480464 |
CTD |
| G |
PTGIR |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
increases response to substance |
ISO |
19 |
47,123,725 |
47,128,354 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
decreases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
decreases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTK2 |
protein tyrosine kinase 2 |
|
multiple interactions |
EXP |
8 |
141,668,481 |
142,011,412 |
RGD:6480464 |
CTD |
| G |
PVRL1 |
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
|
increases expression |
ISO |
11 |
119,508,808 |
119,599,435 |
RGD:6480464 |
CTD |
| G |
RANBP3L |
RAN binding protein 3-like |
|
increases expression |
ISO |
5 |
36,249,104 |
36,302,011 |
RGD:6480464 |
CTD |
| G |
RARRES2 |
retinoic acid receptor responder (tazarotene induced) 2 |
|
multiple interactions |
ISO |
7 |
150,035,407 |
150,038,763 |
RGD:6480464 |
CTD |
| G |
RBM5 |
RNA binding motif protein 5 |
|
increases expression |
ISO |
3 |
50,126,341 |
50,156,397 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases localization |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RETN |
resistin |
|
increases expression |
ISO |
19 |
7,733,972 |
7,735,340 |
RGD:6480464 |
CTD |
| G |
RETN |
resistin |
|
multiple interactions |
ISO |
19 |
7,733,972 |
7,735,340 |
RGD:6480464 |
CTD |
| G |
RETNLB |
resistin like beta |
|
increases expression |
ISO |
3 |
108,474,486 |
108,476,130 |
RGD:6480464 |
CTD |
| G |
RETNLB |
resistin like beta |
|
multiple interactions |
ISO |
3 |
108,474,486 |
108,476,130 |
RGD:6480464 |
CTD |
| G |
RIPK2 |
receptor-interacting serine-threonine kinase 2 |
|
increases expression |
EXP |
8 |
90,769,975 |
90,803,292 |
RGD:6480464 |
CTD |
| G |
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
|
increases expression |
EXP |
X |
20,168,029 |
20,284,750 |
RGD:6480464 |
CTD |
| G |
RPS6KB1 |
ribosomal protein S6 kinase, 70kDa, polypeptide 1 |
|
decreases phosphorylation |
EXP |
17 |
57,970,443 |
58,027,787 |
RGD:6480464 |
CTD |
| G |
RXRA |
retinoid X receptor, alpha |
|
decreases expression |
EXP |
9 |
137,218,316 |
137,332,431 |
RGD:6480464 |
CTD |
| G |
RXRB |
retinoid X receptor, beta |
|
decreases expression |
EXP |
6 |
33,161,362 |
33,168,473 |
RGD:6480464 |
CTD |
| G |
S100A4 |
S100 calcium binding protein A4 |
|
increases expression |
EXP |
1 |
153,516,095 |
153,518,282 |
RGD:6480464 |
CTD |
| G |
S100B |
S100 calcium binding protein B |
|
increases expression |
ISO |
21 |
48,018,531 |
48,025,035 |
RGD:6480464 |
CTD |
| G |
S100G |
S100 calcium binding protein G |
|
increases expression |
ISO |
X |
16,668,281 |
16,672,791 |
RGD:6480464 |
CTD |
| G |
SCN10A |
sodium channel, voltage-gated, type X, alpha subunit |
|
multiple interactions |
ISO |
3 |
38,738,837 |
38,835,501 |
RGD:6480464 |
CTD |
| G |
SCN10A |
sodium channel, voltage-gated, type X, alpha subunit |
|
increases response to substance |
ISO |
3 |
38,738,837 |
38,835,501 |
RGD:6480464 |
CTD |
| G |
SCP2 |
sterol carrier protein 2 |
|
decreases expression |
EXP |
1 |
53,392,901 |
53,517,289 |
RGD:6480464 |
CTD |
| G |
SELE |
selectin E |
|
increases expression |
ISO |
1 |
169,691,781 |
169,703,220 |
RGD:6480464 |
CTD |
| G |
SELE |
selectin E |
|
multiple interactions |
ISO |
1 |
169,691,781 |
169,703,220 |
RGD:6480464 |
CTD |
| G |
SELL |
selectin L |
|
increases expression |
ISO |
1 |
169,659,806 |
169,680,843 |
RGD:6480464 |
CTD |
| G |
SELL |
selectin L |
|
multiple interactions |
ISO |
1 |
169,659,806 |
169,680,843 |
RGD:6480464 |
CTD |
| G |
SENP5 |
SUMO1/sentrin specific peptidase 5 |
|
decreases expression |
ISO |
3 |
196,594,727 |
196,661,585 |
RGD:6480464 |
CTD |
| G |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
decreases expression |
EXP |
7 |
100,770,370 |
100,782,547 |
RGD:6480464 |
CTD |
| G |
SFPQ |
splicing factor proline/glutamine-rich |
|
increases expression |
ISO |
1 |
35,649,201 |
35,658,743 |
RGD:6480464 |
CTD |
| G |
SH3BP5 |
SH3-domain binding protein 5 (BTK-associated) |
|
decreases expression |
ISO |
3 |
15,295,860 |
15,382,901 |
RGD:6480464 |
CTD |
| G |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
|
increases expression |
ISO |
X |
19,552,083 |
19,905,744 |
RGD:6480464 |
CTD |
| G |
SLC12A1 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
|
multiple interactions |
ISO |
15 |
48,498,498 |
48,596,275 |
RGD:6480464 |
CTD |
| G |
SLC12A1 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
|
increases expression |
ISO |
15 |
48,498,498 |
48,596,275 |
RGD:6480464 |
CTD |
| G |
SLC16A10 |
solute carrier family 16, member 10 (aromatic amino acid transporter) |
|
decreases expression |
ISO |
6 |
111,408,781 |
111,544,608 |
RGD:6480464 |
CTD |
| G |
SLC2A4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases expression |
ISO |
17 |
7,185,054 |
7,191,367 |
RGD:6480464 |
CTD |
| G |
SLC37A1 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 1 |
|
decreases expression |
ISO |
21 |
43,919,742 |
44,001,550 |
RGD:6480464 |
CTD |
| G |
SLIT1 |
slit homolog 1 (Drosophila) |
|
increases expression |
ISO |
10 |
98,757,795 |
98,945,683 |
RGD:6480464 |
CTD |
| G |
SOSTDC1 |
sclerostin domain containing 1 |
|
increases expression |
ISO |
7 |
16,501,106 |
16,505,474 |
RGD:6480464 |
CTD |
| G |
SP1 |
Sp1 transcription factor |
|
increases localization |
EXP |
12 |
53,773,979 |
53,810,230 |
RGD:6480464 |
CTD |
| G |
SP1 |
Sp1 transcription factor |
|
multiple interactions |
EXP |
12 |
53,773,979 |
53,810,230 |
RGD:6480464 |
CTD |
| G |
SPP1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
4 |
88,896,802 |
88,904,563 |
RGD:6480464 |
CTD |
| G |
SPP1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
4 |
88,896,802 |
88,904,563 |
RGD:6480464 |
CTD |
| G |
SRC |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
20 |
35,973,088 |
36,033,821 |
RGD:6480464 |
CTD |
| G |
SRC |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
increases activity |
ISO |
20 |
35,973,088 |
36,033,821 |
RGD:6480464 |
CTD |
| G |
SRC |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
20 |
35,973,088 |
36,033,821 |
RGD:6480464 |
CTD |
| G |
SST |
somatostatin |
|
increases secretion |
ISO |
3 |
187,386,694 |
187,388,201 |
RGD:6480464 |
CTD |
| G |
SST |
somatostatin |
|
decreases expression |
ISO |
3 |
187,386,694 |
187,388,201 |
RGD:6480464 |
CTD |
| G |
SST |
somatostatin |
|
increases expression |
ISO |
3 |
187,386,694 |
187,388,201 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
multiple interactions |
ISO |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STEAP3 |
STEAP family member 3, metalloreductase |
|
multiple interactions |
ISO |
2 |
119,981,384 |
120,023,228 |
RGD:6480464 |
CTD |
| G |
SUV39H1 |
suppressor of variegation 3-9 homolog 1 (Drosophila) |
|
decreases expression |
ISO |
X |
48,555,131 |
48,567,407 |
RGD:6480464 |
CTD |
| G |
SYNGAP1 |
synaptic Ras GTPase activating protein 1 |
|
affects response to substance |
ISO |
6 |
33,387,847 |
33,421,466 |
RGD:6480464 |
CTD |
| G |
SYT7 |
synaptotagmin VII |
|
increases expression |
ISO |
11 |
61,281,188 |
61,348,344 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
decreases expression |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
increases expression |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
increases secretion |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
decreases expression |
EXP |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
increases secretion |
EXP |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
increases expression |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
increases secretion |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
decreases expression |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
decreases expression |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
decreases secretion |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
increases secretion |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
7 |
97,361,271 |
97,369,784 |
RGD:6480464 |
CTD |
| G |
TAC3 |
tachykinin 3 |
|
decreases expression |
ISO |
12 |
57,403,781 |
57,410,344 |
RGD:6480464 |
CTD |
| G |
TACR1 |
tachykinin receptor 1 |
|
increases expression |
ISO |
2 |
75,273,590 |
75,426,645 |
RGD:6480464 |
CTD |
| G |
TACR2 |
tachykinin receptor 2 |
|
decreases expression |
ISO |
10 |
71,163,958 |
71,176,674 |
RGD:6480464 |
CTD |
| G |
TAL1 |
T-cell acute lymphocytic leukemia 1 |
|
increases expression |
ISO |
1 |
47,681,963 |
47,695,443 |
RGD:6480464 |
CTD |
| G |
TAL1 |
T-cell acute lymphocytic leukemia 1 |
|
multiple interactions |
ISO |
1 |
47,681,963 |
47,695,443 |
RGD:6480464 |
CTD |
| G |
TEK |
TEK tyrosine kinase, endothelial |
|
increases expression |
ISO |
9 |
27,109,147 |
27,230,172 |
RGD:6480464 |
CTD |
| G |
TEK |
TEK tyrosine kinase, endothelial |
|
increases expression |
EXP |
9 |
27,109,147 |
27,230,172 |
RGD:6480464 |
CTD |
| G |
TEK |
TEK tyrosine kinase, endothelial |
|
multiple interactions |
ISO |
9 |
27,109,147 |
27,230,172 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGFB2 |
transforming growth factor, beta 2 |
|
increases expression |
ISO |
1 |
218,518,676 |
218,617,961 |
RGD:6480464 |
CTD |
| G |
TGFB2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
1 |
218,518,676 |
218,617,961 |
RGD:6480464 |
CTD |
| G |
TGFB3 |
transforming growth factor, beta 3 |
|
multiple interactions |
ISO |
14 |
76,424,442 |
76,448,092 |
RGD:6480464 |
CTD |
| G |
TGFB3 |
transforming growth factor, beta 3 |
|
increases expression |
ISO |
14 |
76,424,442 |
76,448,092 |
RGD:6480464 |
CTD |
| G |
THOP1 |
thimet oligopeptidase 1 |
|
increases expression |
ISO |
19 |
2,785,506 |
2,813,599 |
RGD:6480464 |
CTD |
| G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
47,441,690 |
47,446,190 |
RGD:6480464 |
CTD |
| G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
ISO |
X |
47,441,690 |
47,446,190 |
RGD:6480464 |
CTD |
| G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
47,441,690 |
47,446,190 |
RGD:6480464 |
CTD |
| G |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
ISO |
17 |
76,849,059 |
76,921,472 |
RGD:6480464 |
CTD |
| G |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
ISO |
17 |
76,849,059 |
76,921,472 |
RGD:6480464 |
CTD |
| G |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
|
increases expression |
EXP |
22 |
33,196,802 |
33,259,028 |
RGD:6480464 |
CTD |
| G |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
|
multiple interactions |
ISO |
22 |
33,196,802 |
33,259,028 |
RGD:6480464 |
CTD |
| G |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
|
increases expression |
ISO |
22 |
33,196,802 |
33,259,028 |
RGD:6480464 |
CTD |
| G |
TLR4 |
toll-like receptor 4 |
|
increases expression |
ISO |
9 |
120,466,453 |
120,479,769 |
RGD:6480464 |
CTD |
| G |
TLR4 |
toll-like receptor 4 |
|
multiple interactions |
ISO |
9 |
120,466,453 |
120,479,769 |
RGD:6480464 |
CTD |
| G |
TMEM37 |
transmembrane protein 37 |
|
increases expression |
ISO |
2 |
120,189,446 |
120,196,096 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
decreases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
decreases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNFRSF10A |
tumor necrosis factor receptor superfamily, member 10a |
|
increases expression |
EXP |
8 |
23,048,970 |
23,082,680 |
RGD:6480464 |
CTD |
| G |
TNFRSF10B |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
EXP |
8 |
22,877,646 |
22,926,700 |
RGD:6480464 |
CTD |
| G |
TNFRSF10B |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
EXP |
8 |
22,877,646 |
22,926,700 |
RGD:6480464 |
CTD |
| G |
TNFRSF10B |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
EXP |
8 |
22,877,646 |
22,926,700 |
RGD:6480464 |
CTD |
| G |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
|
affects expression |
ISO |
13 |
24,144,509 |
24,250,244 |
RGD:6480464 |
CTD |
| G |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
|
multiple interactions |
ISO |
13 |
24,144,509 |
24,250,244 |
RGD:6480464 |
CTD |
| G |
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
|
increases expression |
EXP |
12 |
6,437,923 |
6,451,283 |
RGD:6480464 |
CTD |
| G |
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
|
increases expression |
ISO |
12 |
6,437,923 |
6,451,283 |
RGD:6480464 |
CTD |
| G |
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
|
multiple interactions |
ISO |
12 |
6,437,923 |
6,451,283 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
EXP |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
EXP |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases activity |
EXP |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
EXP |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases response to substance |
EXP |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
ISO |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TOM1 |
target of myb1 (chicken) |
|
decreases expression |
ISO |
22 |
35,695,268 |
35,743,987 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases expression |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases phosphorylation |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
affects response to substance |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases degradation |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases expression |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TPI1 |
triosephosphate isomerase 1 |
|
increases expression |
EXP |
12 |
6,976,584 |
6,980,110 |
RGD:6480464 |
CTD |
| G |
TRAFD1 |
TRAF-type zinc finger domain containing 1 |
|
increases expression |
ISO |
12 |
112,563,349 |
112,591,408 |
RGD:6480464 |
CTD |
| G |
TRPC5 |
transient receptor potential cation channel, subfamily C, member 5 |
|
increases expression |
ISO |
X |
111,017,542 |
111,326,004 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases activity |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases activity |
EXP |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases activity |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
affects response to substance |
EXP |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
decreases response to substance |
EXP |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
affects response to substance |
EXP |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases activity |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases response to substance |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
affects response to substance |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases response to substance |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
affects binding |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
decreases expression |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
decreases expression |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases expression |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases activity |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
| G |
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
17 |
3,468,740 |
3,512,705 |
RGD:6480464 |
CTD |
Term paths to the root
|